Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 5th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany The word Corona is still on everyone’s lips. In the wake of the virus, however, other pathogens are also spreading. Some benefit from the pandemic, among them […]
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 4th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany According to Professor Hans Rieth, the unforgotten master of mycological entertainment, the clinical eye is often a relative of the evil eye. He described the problem of
Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN Medizinische Labordiagnostika AG. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect, in the European countries of Portugal, Italy, Turkey and Poland. The test is also expected
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 3rd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany The marvellous city of Edinburgh inspired several novelists such as Joanne K. Rowling (“Harry Potter” and Robert Louis Stevenson (“The strange case of Dr Jekyll and Mr
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 2nd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Professor Seebacher, a leading dermatomycologist, always warned us never to end onychomycosis therapy too early. Here are the reasons: Mycosis does not confer immunity. But, above all,
